McAdam LLC’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
McAdam LLC's BSX Position: Q3 2026 in Review
McAdam LLC increased its Boston Scientific (BSX) stake by 24% in Q3 2026, buying an estimated $59.4K and bringing the position to 6,601 shares worth $288K. The position accounts for 0.01% of the portfolio, ranked #407.
McAdam LLC first reported a position in BSX in Q2 2018 and has held it in 12 quarters since. The position peaked at $332K in Q4 2024. 406 funds tracked by Wall St. Rank hold BSX as of Q3 2026.
- McAdam LLC held 6,601 shares of Boston Scientific worth $288K as of Q3 2026.
- McAdam LLC bought 1,283 Boston Scientific shares in Q3 2026, an estimated $59.4K.
- Boston Scientific made up 0.01% of McAdam LLC's portfolio in Q3 2026, its #407 holding.
- McAdam LLC first reported a position in Boston Scientific in Q2 2018 and has held it in 12 quarters since.
- McAdam LLC's Boston Scientific position peaked at $332K in Q4 2024.
- 406 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.
Based on McAdam LLC's 13F filing for Q3 2026, filed 21 Oct 2026.